Onconova
Therapeutics Inc. Logs $50 Million
Philadelphia
Business Journal by Peter Key, Reporter
Onconova
Therapeutics Inc. has raised $1 short of $50 million in a private-equity sale,
according to a Form D filing it made Monday with the Securities and Exchange
Commission. The Newtown, Pa.,
biotechnology company said it will use the money for working capital and
general corporate purposes.
Onconova raised a little more than $26.4 million in a two-part private-equity sale earlier this year. It raised $7.05 million in May and the remainder in July. The company is developing new drugs for treatment of cancer and radiation injury. The Form D filings were provided to the Philadelphia Business Journal by FormDs.com.
Click Here To Read More:
http://www.biospace.com/News/onconova-therapeutics-inc-logs-50-million/269986
Save 40-60% On Preowned Lab Equipment, Click Here To Read More:
http://www.ssllc.com/FindEquipment/LabEquipment.aspx
http://www.biospace.com/News/onconova-therapeutics-inc-logs-50-million/269986
Save 40-60% On Preowned Lab Equipment, Click Here To Read More:
http://www.ssllc.com/FindEquipment/LabEquipment.aspx